Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trialUlrike Leiter, Claus Garbe, Percy Lehmann et al.|The Lancet Oncology|2016Cited by 704
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel NodeUlrike Leiter, Rudolf Stadler, Cornelia Mauch et al.|Journal of Clinical Oncology|2019Cited by 254
Final analysis of DECOG-SLT trial: Survival outcomes of complete lymph node dissection in melanoma patients with positive sentinel node.Ulrike Leiter, Claus Garbe, Rudolf Stadler et al.|Journal of Clinical Oncology|2018Cited by 19
Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial.Ulrike Leiter, Claus Garbe, Rudolf Stadler et al.|Journal of Clinical Oncology|2015Cited by 18
Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial.Ulrike Leiter, Claus Garbe, Rudolf Stadler et al.|Journal of Clinical Oncology|2015Cited by 5